Skip to main content

Advertisement

Log in

Midodrine for Orthostatic Hypotension: A Systematic Review and Meta-Analysis of Clinical Trials

  • Review Article
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

ABSTRACT

OBJECTIVE

To perform a systematic review and meta-analysis of clinical trials evaluating the efficacy and safety of midodrine in orthostatic hypotension (OH).

METHODS

We searched major databases and related conference proceedings through June 30, 2012. Two reviewers independently selected studies and extracted data. Random-effects meta-analysis was used to pool the outcome measures across studies.

RESULTS

Seven trials were included in the efficacy analysis (enrolling 325 patients, mean age 53 years) and two additional trials were included in the safety analysis. Compared to placebo, the mean change in systolic blood pressure was 4.9 mmHg (p = 0.65) and the mean change in mean arterial pressure from supine to standing was −1.7 mmHg (p = 0.45). The change in standing systolic blood pressure before and after giving midodrine was 21.5 mmHg (p < 0.001). A significant improvement was seen in patients’ and investigators’ global assessment symptoms scale (a mean difference of 0.70 [95 % CI 0.30–1.09; p < 0.001] and 0.80 [95 % CI 0.76–0.85; p < 0.001], respectively). There was a significant increase in risk of piloerection, scalp pruritis, urinary hesitancy/retention, supine hypertension and scalp paresthesia after giving midodrine. The quality of evidence was limited by imprecision, heterogeneity and increased risk of bias.

CONCLUSION

There is insufficient and low quality evidence to support the use of midodrine for OH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1.
Figure 2.
Figure 3.
Figure 4.

Similar content being viewed by others

REFERENCES

  1. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161:46–8.

    Article  PubMed  Google Scholar 

  2. Low PA. Update on the evaluation, pathogenesis, and management of neurogenic orthostatic hypotension: introduction. Neurology. 1995;45:S4–5.

    Article  PubMed  CAS  Google Scholar 

  3. Low PA, Singer W. Management of neurogenic orthostatic hypotension: an update. Lancet Neurol. 2008;7:451–8.

    Article  PubMed  Google Scholar 

  4. Somberg JC. The midodrine withdrawal. Am J Ther. 2010;17:445.

    Article  PubMed  Google Scholar 

  5. Dhruva SS, Redberg RF. Accelerated approval and possible withdrawal of midodrine. JAMA. 2010;304:2172–3.

    Article  PubMed  CAS  Google Scholar 

  6. Mitka M. FDA takes slow road toward withdrawal of drug approved with fast-track process. JAMA. 2011;305:982–4.

    Article  PubMed  CAS  Google Scholar 

  7. Mitka M. Trials to address efficacy of midodrine 18 years after it gains FDA approval. JAMA. 2012;307:1124–7.

    Article  PubMed  CAS  Google Scholar 

  8. Somberg JC. The midodrine withdrawal. Am J Ther. 2010;17:445.

    Article  PubMed  Google Scholar 

  9. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.

    Google Scholar 

  10. Higgins JP, Green S, Eds. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org 2011.

  11. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.

    Article  PubMed  Google Scholar 

  12. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336:995–8.

    Article  PubMed  Google Scholar 

  13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed  Google Scholar 

  15. Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med. 1995;99:604–10.

    Article  PubMed  CAS  Google Scholar 

  16. Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95:38–48.

    Article  PubMed  CAS  Google Scholar 

  17. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA. 1997;277:1046–51.

    Article  PubMed  CAS  Google Scholar 

  18. Schrage WG, Eisenach JH, Dinenno FA, et al. Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure. J Appl Physiol. 2004;97:1978–84.

    Article  PubMed  CAS  Google Scholar 

  19. Wecht JM, Rosado-Rivera D, Handrakis JP, Radulovic M, Bauman WA. Effects of midodrine hydrochloride on blood pressure and cerebral blood flow during orthostasis in persons with chronic tetraplegia. Arch Phys Med Rehabil. 2010;91:1429–35.

    Article  PubMed  Google Scholar 

  20. Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51:120–4.

    Article  PubMed  CAS  Google Scholar 

  21. Axelrod FB, Krey L, Glickstein JS, Weider Allison J, Friedman D. Preliminary observations on the use of midodrine in treating orthostatic hypotension in familial dysautonomia. J Auton Nerv Syst. 1995;55:29–35.

    Article  PubMed  CAS  Google Scholar 

  22. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab. 1998;83:339–43.

    Article  PubMed  CAS  Google Scholar 

  23. Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology. 1988;38:951–6.

    Article  PubMed  CAS  Google Scholar 

  24. Logan IC, Witham MD. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing. 2012;41:587–94.

    Article  PubMed  Google Scholar 

  25. Pathak A, Raoul V, Montastruc JL, Senard JM. Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France. Eur J Clin Pharmacol. 2005;61:471–4.

    Article  PubMed  CAS  Google Scholar 

  26. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53:1119–29.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Christian Jeng-Singh (Mayo Clinic, Rochester, MN) for his help in the translation of the German articles.

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ajay K. Parsaik MD.

Additional information

Ajay K. Parsaik and Balwinder Singh contributed equally to this manuscript.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Online Appendix

(PDF 71 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parsaik, A.K., Singh, B., Altayar, O. et al. Midodrine for Orthostatic Hypotension: A Systematic Review and Meta-Analysis of Clinical Trials. J GEN INTERN MED 28, 1496–1503 (2013). https://doi.org/10.1007/s11606-013-2520-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-013-2520-3

KEY WORDS

Navigation